Apis Capital Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Apis Capital Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.32M	Buy	+39,000	New	+$1.15M	2.08%	13

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Apis Capital Advisors's DCPH Position: Q3 2019 in Review

Apis Capital Advisors opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2019: 39,000 shares worth $1.32M. The stake represents 2.08% of the portfolio and ranks #13 among its holdings.

122 funds tracked by Wall St. Rank hold DCPH as of Q3 2019.

Apis Capital Advisors held 39,000 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $1.32M as of Q3 2019.
Deciphera Pharmaceuticals, Inc. Common Stock was a new Apis Capital Advisors position in Q3 2019.
Deciphera Pharmaceuticals, Inc. Common Stock made up 2.08% of Apis Capital Advisors's portfolio in Q3 2019, its #13 holding.
122 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Apis Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.